Pharmacopsychiatry 1995; 28: 80-90
DOI: 10.1055/s-2007-979624
Original Paper

© Georg Thieme Verlag Stuttgart · New York

Serotonin Receptors and Animal Models of Aggressive Behavior

B. Olivier1 , 2 , J. Mos1 , R. van Oorschot1 , R. Hen3
  • 1CNS-Pharmacology, Solvay Duphar B.V., Weesp, The Netherlands
  • 2Rudolf Magnus Institute for Neurosciences, Department of Psychopharmacology, Faculty of Pharmacy, Utrecht University, Utrecht, The Netherlands
  • 3Columbia University, Center for Neurobiology and Behavior, New York, USA
Further Information

Publication History

Publication Date:
23 April 2007 (online)

Abstract

Various models of rodent agonistic behavior are described, which differentiate between offensive and defensive/flight models. Particular attention is given to one male and one female paradigm for offensive aggression, i. e. resident-intruder or territorial aggression (Rl) and maternal aggression (MA). After an overview of the serotonin (5-HT) system in the CNS, a description is given of the ligands available. Subsequently, the effects of various drugs affecting serotonergic transmission in the Rl- and MA-paradigms are described. The 5-HT1A receptor agonists buspirone, ipsapirone, and 8-OH-DPAT decreased aggression in Rl and MA, but simultaneously led to a marked decrease in social interest and activity, indicative of a nonspecific antiaggressive profile. Nonselective 5-HT1 receptor agonists, such as RU24969, eltoprazine, and TFMPP reduced aggression quite specifically, did not decrease social interest or exploration, and sometimes even increased these behaviors. In Rl and MA, the behavioral effects of these drugs were roughly similar. In contrast, MA was more sensitive to treatment with the 5-HT reuptake blocker fluvoxamine, which blocked Rl aggression nonspecifically at the highest dose only. DOI, a 5-HT2A/2C# receptor agonist, decreased aggressive behavior and increased inactivity, without affecting social interest and exploration in Rl as well as MA. This was, however, accompanied by "wet dog shaking", characteristic of 5-HT2 receptor stimulation. The nonspecific 5-HT receptor agonist (and 5-HT3 receptor antagonist) quipazine also induced "wet dog shaking" at doses which suppressed aggression, social interest, and exploration but increased inactive behaviors (sitting and lying). The discussion delineates a specific role for 5-HT1B receptor-subtype involvement in the modulation of aggression, with the restrictions we clearly face with regard to the lack of specific serotonergic agonists and antagonists for certain receptor subtypes. By and large, male and female rats react similarly to treatment with serotonergic drugs, and this fact underlines the consistent role of 5-HT in different forms of aggression.